发明名称 |
Compositions and methods for diagnosing or treating neutrophil-mediated inflammatory disease |
摘要 |
Disclosed are nanoparticle compositions comprising nanoparticles prepared from denatured, cross-linked albumin and a therapeutic agent for treating a neutrophil-mediated inflammation, and methods of treating neutrophil-mediated inflammation using the compositions. |
申请公布号 |
US9561192(B2) |
申请公布日期 |
2017.02.07 |
申请号 |
US201414316036 |
申请日期 |
2014.06.26 |
申请人 |
The Board of Trustees of the University of Illinois |
发明人 |
Wang Zhenjia;Cho Jaehyung;Malik Asrar |
分类号 |
A61K31/05;A61K9/16;G01N33/543;G01N33/50;A61K9/51;A61K31/573 |
主分类号 |
A61K31/05 |
代理机构 |
Valauskas Corder LLC |
代理人 |
Valauskas Corder LLC |
主权项 |
1. A method of delivering an agent to activated neutrophils comprising contacting the activated neutrophils with nanoparticles, each nanoparticle consisting of denatured, cross-linked albumin and the agent, the agent selected from a therapeutic agent and a detectable moiety, the nanoparticles selectively binding to and internalized by the activated neutrophils. |
地址 |
Urbana IL US |